Cargando…
Should A1C Targets Be Individualized for All People With Diabetes?: Arguments for and against
Autores principales: | Teoh, Hwee, Home, Philip, Leiter, Lawrence A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632160/ https://www.ncbi.nlm.nih.gov/pubmed/21525454 http://dx.doi.org/10.2337/dc11-s217 |
Ejemplares similares
-
Should C-Reactive Protein Be a Target of Therapy?
por: Oh, Jisun, et al.
Publicado: (2011) -
Should We Start All Patients with Diabetic Retinopathy on Fenofibrates?
por: Koshy, Jacob, et al.
Publicado: (2013) -
Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011) -
Insulin Therapy and Cancer
por: Home, Philip
Publicado: (2013) -
Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections from a Diabetes Care Editors’ Expert Forum
por: Raz, Itamar, et al.
Publicado: (2013)